Home > Cashflow Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Cash Flow from Operating Activities

    Back to Cashflow Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹3,023 Cr₹2,585 Cr₹3,266 Cr₹2,368 Cr₹1,803 Cr

What is the latest Cash Flow from Operating Activities ratio of TORRENT PHARMACEUTICALS ?

The latest Cash Flow from Operating Activities ratio of TORRENT PHARMACEUTICALS is ₹3,023 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹3,023 Cr
Mar2025₹2,585 Cr
Mar2024₹3,266 Cr
Mar2023₹2,368 Cr
Mar2022₹1,803 Cr

How is Cash Flow from Operating Activities of TORRENT PHARMACEUTICALS Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹3,023 Cr
16.93
Mar2025 ₹2,585 Cr
-20.85
Mar2024 ₹3,266 Cr
37.92
Mar2023 ₹2,368 Cr
31.34
Mar2022 ₹1,803 Cr -

Compare Cash Flow from Operating Activities of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹181,641.0 Cr 2.9% 2.1% 30.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹457,073.0 Cr 8.1% 9.3% 9% Stock Analytics
DIVIS LABORATORIES ₹307,147.0 Cr 10.5% 18% 51.4% Stock Analytics
DR REDDYS LABORATORIES ₹115,685.0 Cr -0.1% 16% 14.6% Stock Analytics
CIPLA ₹113,589.0 Cr 1.4% 8.1% -6.8% Stock Analytics
MANKIND PHARMA ₹109,911.0 Cr 4% 7.5% 5.8% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

2.9%

2.1%

30.7%

SENSEX

5.5%

13.3%

-3.4%


You may also like the below Video Courses